
Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
New research highlights significant economic benefit of clinical trials in the Lone Star State and opportunities for Texas patients to contribute to medical progress
AUSTIN, Texas, March 20, 2013 /PRNewswire/ --
| WHO: |
Sen. Bob Deuell (R) – Greenville; Rep. Jim Murphy (R) – Houston; Tom Kowalski, |
| President, Texas Healthcare and Bioscience Institute; Dr. Curtis Triplitt, Asst. Professor, Diabetes/Medicine, The University of Texas Health Science Center at San Antonio, Texas Diabetes Institute; and Jeff Trewhitt, Senior Communications Director at PhRMA |
|
| WHAT: |
A press conference on clinical trials of new medicines being conducted in Texas by biopharmaceutical research companies in collaboration with local research institutions, including The University of Texas and the release of a new report – "Research in Your Backyard: Pharmaceutical Clinical Trials in Texas" |
| WHEN: |
Monday, March 25 |
| 12:30-1:30 p.m. |
|
| WHERE: |
Lt. Governor's Press Conference Room, Texas State Capitol, Room 2E.9 |
| WHY: |
To emphasize the importance of biopharmaceutical research companies to Texas patients and the state's economy, and the need for policies that support medical innovation; new clinical trials are a steady source of revenue and business for local research institutions |
SOURCE Texas Healthcare and Bioscience Institute
Share this article